1. GPCR/G Protein Neuronal Signaling Membrane Transporter/Ion Channel
  2. Adrenergic Receptor Sodium Channel Potassium Channel
  3. ICI 147798

ICI 147798 is an orally effective β-adrenoceptor antagonist with a pKB of 9.1 (in guinea pig right atrium) and 8.8 (in guinea pig trachea). ICI 147798 acts as a diuretic and intraocular pressure-lowering agent. ICI 147798 blocks β-adrenoceptors, inhibits isoproterenol-induced tachycardia and vasodepressor responses, exhibits slowly dissociating, insurmountable antagonism against β1-adrenoceptors, and shows surmountable competitive antagonism against β2-adrenoceptors. ICI 147798 induces natriuresis and kaliuresis, inhibits sodium transport, and reduces intraocular pressure.

For research use only. We do not sell to patients.

ICI 147798

ICI 147798 Chemical Structure

CAS No. : 83812-65-1

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products

View All Adrenergic Receptor Isoform Specific Products:

View All Sodium Channel Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

ICI 147798 is an orally effective β-adrenoceptor antagonist with a pKB of 9.1 (in guinea pig right atrium) and 8.8 (in guinea pig trachea). ICI 147798 acts as a diuretic and intraocular pressure-lowering agent. ICI 147798 blocks β-adrenoceptors, inhibits isoproterenol-induced tachycardia and vasodepressor responses, exhibits slowly dissociating, insurmountable antagonism against β1-adrenoceptors, and shows surmountable competitive antagonism against β2-adrenoceptors. ICI 147798 induces natriuresis and kaliuresis, inhibits sodium transport, and reduces intraocular pressure[1][2][3].

IC50 & Target[1]

β-adrenoceptor

8.8 (pkB)

In Vitro

ICI 147798 inhibits Na+ transport in isolated toad bladder preparations with mucosal and serosal IC50 values of 56 μM and 120 μM, respectively[1].
ICI 147798 acts as a beta-adrenoceptor antagonist in isolated guinea pig right atria with a pKB value of 9.1[1].
ICI 147798 acts as a beta-adrenoceptor antagonist in isolated guinea pig trachea with a pKB value of 8.8[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

ICI 147798 (0.125-0.75%; eye drop; single dose) produces statistically significant, concentration-dependent intraocular pressure (IOP)-lowering effects in unanesthetized New Zealand rabbits in a water load-induced high IOP model, with an ED50 of 0.27% for IOP reduction and a duration of action of 5 hours at the 0.5% dose[2].
ICI 147798 (0.1-1.0 mg/kg; intravenous administration) acts as a potent intravenous β-adrenergic receptor antagonist in unanesthetized New Zealand rabbits, with an ED50 of 0.23 mg/kg for blocking isoproterenol-induced tachycardia[2].
ICI 147798 (0.5%; topical administration; single dose, twice daily for 4 consecutive days) exerts no significant blocking effect on isoproterenol-induced tachycardia in unanesthetized New Zealand rabbits, even after twice-daily administration for 4 consecutive days[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: New Zealand rabbits (adult, 2-5 kg, both sexes, water-load-induced ocular hypertension model)[2]
Dosage: 300 μl, 0.5%; 200 μl, 0.5%; 200 μl, 0.125%; 200 μl, 0.25%; 100 μl, 0.5%; 200 μl, 0.75%; 100 μl, 0.75%
Administration: eye drop; single dose
Result: Reduced mean water-load-induced IOP increase to 4.0 mmHg at 1 hour, 5.3 mmHg at 3 hours, and 6.2 mmHg at 5 hours after 300 μl, 0.5% topical dosing to one eye.
Reduced mean water-load-induced IOP increase to 4.5 mmHg (left eye) and 4.0 mmHg (right eye) at 1 hour after 200 μl, 0.5% topical dosing to both eyes (P<0.05 vs control).
Exhibited concentration-dependent IOP-lowering effect with an ED50 of 0.27%.
Reduced mean water-load-induced IOP increase to 5.5 mmHg (left eye) and 5.5 mmHg (right eye) after 100 μl, 0.5% dosing in 5% PEG 400 + 5% Pluronic F127 vehicle.
Showed no enhanced IOP-lowering efficacy with 0.75% concentration or 200 μl volume, with mean ΔmmHg values ranging from 5.0 to 5.5 mmHg.
Molecular Weight

515.99

Formula

C24H30ClN7O4

CAS No.
SMILES

O=C(C1=NC(Cl)=C(N)N=C1N)NC(C)(C)C(NCCNCC(COC2=CC=CC3=C2C=CC=C3)O)=O

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
ICI 147798
Cat. No.:
HY-182635
Quantity:
MCE Japan Authorized Agent: